Merck (NYSE: MRK) EVP nets more shares after RSU vesting
Rhea-AI Filing Summary
Merck & Co., Inc. executive Richard R. DeLuca, EVP and President of Merck Animal Health, reported routine equity compensation activity. On April 29, 2026, he exercised 2,518 restricted stock units, receiving an equivalent number of Merck common shares.
To cover tax obligations, 1,241 common shares were disposed of at $110.03 per share through a tax-withholding transaction, leaving a net increase in his directly held stock. After these transactions, DeLuca directly holds 161,537.07 shares of common stock and indirectly holds 1,320.9907 shares through a 401(k) plan. Footnotes note that restricted stock units convert into one common share each and vest in three equal installments on April 29, 2026, 2027, and 2028, with remaining units outstanding.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 2,518 | $0.00 | -- |
| Exercise | Common Stock | 2,518 | $110.03 | $277K |
| Tax Withholding | Common Stock | 1,241 | $110.03 | $137K |
| holding | Common Stock - 401(k) Plan | -- | -- | -- |
Footnotes (1)
- Holdings include shares acquired in dividend reinvestment transactions. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.